Publication details

Radiotherapy in early stage follicular lymphoma: is it really the gold standard?

Authors

JANÍKOVÁ Andrea

Year of publication 2015
Type Article in Periodical
Magazine / Source Leukemia and Lymphoma
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.3109/10428194.2015.1049172
Field Other medical specializations
Keywords Radiotherapy; follicular lymphoma
Description Major changes have occurred during the last few years in the management of follicular lymphoma (FL), leading to substantial improvement in prognosis and overall survival. One of the turning points was the introduction of rituximab (R). Th is monoclonal antibody is now the cornerstone of therapy for advanced disease and is now a standard part of treatment. However, for the 25 – 30% patients with localized disease (stage I or II), involved-fi eld radiotherapy (IFRT) remains the gold standard [1]. We can indeed ask if this treatment modality is truly the gold standard?

You are running an old browser version. We recommend updating your browser to its latest version.

More info